Synergy Pharmaceuticals, Inc. (SGYP) Shares Active after Upgrade at Zacks Investment Research

Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) shares fell back in value on Wednesday January 25 on slower trade volume than normal after a number of analysts weighed in on the investing value of the stock with a upgraded rating.

Meanwhile, the Dow Jones Industrial Average on Wednesday crossed the 20,000 level for the first time, while the S&P 500 and Nasdaq Composite also traded in record territory shortly after the market opened

The Dow Jones Industrial Average DJIA, +0.60% advanced 100 points, or 0.5%, to 20,012,
The S&P 500 index SPX, +0.55% gained 10 points, or 0.5%, to 2,289, with eight of the main 11 sectors trading higher.

The Nasdaq Composite index COMP, +0.66% was 30 points, or 0.6%, higher at 5,630.

All three main indexes set intraday records shortly after the opening bell.

Analysts at Zacks Investment Research upgraded shares of Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) from Hold to Buy today. With a rating of Buy on the shares, Synergy Pharmaceuticals, Inc. has a 52-week high of $6.97. The one-year price target of $11.50 is higher than the opening price of $5.49, resulting a number of other analysts to comment on the company in recent days. Usually, after analysts publish an upgrade report on a stock, they will subsequently issue sporadic updates, such as a price target change.

Shares of Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) opened at $5.49 yesterday and traded in a range between, $5.37 and $5.64, and last traded at $5.42, which is a dip of $0.11 over the previous closing price.

Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) currently has a market cap of 975.35M.

Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) Average Daily Trading Volume

The stock’s average daily volume is 4,940,120 shares out of a total float 147,990,000 and some 1,075,537 shares crossed the trading desk yesterday, 25 percent lower than the norm. lower than normal. Look for trading volume to pick up in the coming days as investors often use upticks in trading volume to identify heavy volume accumulation or distribution by institutional investors.

As with all potential breakouts, investors look for volume to be at least 40%-50% higher than normal on the breakout to show that fund managers and other professional investors are jumping in.

Institutional sponsorship simply refers to ownership of a stock by mutual funds, banks, pension funds and other large institutions.

Institutional investors such as these have teams of analysts researching thousands of stocks, so it is good corroboration to see them buying a stock you’re considering.

Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) Moving Averages

A moving average can also act as support or resistance. In an uptrend a 50-day, 100-day or 200-day moving average may act as a support level, as shown in the figure below.

This is because the average acts like a floor (support), so the price bounces up off of it.

In a downtrend a moving average may act as resistance; like a ceiling, the price hits it and then starts to drop again.

By spotting trends, moving averages allow traders to make those trends work in their favor and increase the number of successful trades.

Trades for Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) have ranged from $2.50 – 6.97, and the stock now has a 50-day MA of $5.82 and 200-day MA of $5.15. Today’s last price is 22.24%% lower than the 52 week high of $6.97.

Earnings growth is an important factor to consider when buying stocks and investors identify companies that have grown their earnings at least 25% or more for 3 consecutive years.

DISCLOSURE: The views and opinions expressed in this article do not represent the views of the website. Readers should not consider statements made by the author as formal recommendations and should consult their financial adviser before making any investment decisions. To read our full disclosure, please see our terms and conditions page.

Latest News

Leave a Reply